Epic Bio Reports New Data on Hypercompact Cas Proteins Optimized for Broad Therapeutic Applicability
– Data being presented at ESGCT reflect improvements upon CasMINI, previously the smallest Cas protein known to work in human cells – – Company’s additional poster presentations report on progress of epigenetic editing platform and lead candidate EPI-321 – SOUTH SAN FRANCISCO, Calif. — October 26, 2023 — Epic Bio, a biotechnology company developing therapies to … Read more